Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 101–200 of 1,001
Cardiac Side-effects From Breast Cancer Radiotherapy
Taylor, C. W., & Kirby, A. M. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.06.007 · Cited by 205
“4% per Gy) [8] is probably more relevant than the doseeresponse relationship in randomised data because it included individual patient information on the regimen used, on cardiac outcomes and cardiac risk factors before radiotherapy.”
BackgroundInfluentialSelf-citationReview of deep inspiration breath‐hold techniques for the treatment of breast cancer
Latty, D., Stuart, K. E., Wang, W., & Ahern, V. (2015) · Journal of Medical Radiation Sciences · doi:10.1002/jmrs.96 · Cited by 206
“A large retrospective study by Darby et al.6 compared the ratio of patients who had received radiation therapy to the left breast and died of heart disease to that of the right breast.”
BackgroundInfluentialCardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
Totzeck, M., Schuler, M., Stuschke, M., Heusch, G., & Rassaf, T. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.038 · Cited by 206
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
Worni, M., Akushevich, I., Greenup, R., Sarma, D., Ryser, M. D., Myers, E. R., & Hwang, E. S. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv263 · Cited by 203
Space radiation risks for astronauts on multiple International Space station missions
Cucinotta, F. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096099 · Cited by 203
“Human studies on circulatory disease risks are a more recent concern from epidemiology analysis of low dose radiation exposures [31,42,43].”
BackgroundIonising radiation and cardiovascular disease: systematic review and meta-analysis
Little, M. P., Azizova, T. V., Richardson, D. B., Tapio, S., Bernier, M., Kreuzer, M., Cucinotta, F. A., Bаzyка, D., Chumak, V. V., Ivanov, V. K., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072924 · Cited by 215
Recent advances in Surface Guided Radiation Therapy
Freislederer, P., Kügele, M., Öllers, M., Swinnen, A., Sauer, T.-O., Bert, C., Giantsoudi, D., Corradini, S., & Batista, V. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01629-w · Cited by 172
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Denlinger, C. S., Sanft, T., Baker, K. S., Broderick, G., Demark-Wahnefried, W., Friedman, D. L., Goldman, M., Hudson, M., Khakpour, N., King, A., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0078 · Cited by 199
Recent advances in radiotherapy of breast cancer
Haussmann, J., Corradini, S., Nestle-Kraemling, C., Bölke, E., Njanang, F. J. D., Tamaskovics, B., Orth, K., Ruckhaeberle, E., Fehm, T., Mohrmann, S., et al. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01501-x · Cited by 180
Groarke, J. D., Nguyen, P. L., Nohria, A., Ferrari, R., Cheng, S., & Moslehi, J. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht114 · Cited by 193
“1990(100) 26 pts with HD (21 with no known CAD) 38 (21-45) years 40 Gy 15 (4-20) years 2/23 abnormal; 12/23 ambiguous (uneven isotope uptake, not classic for any pattern of CAD); 9/23 normal Cross-sectional study, single center”
BackgroundIliescu, C. A., Grines, C. L., Herrmann, J., Yang, E. H., Cilingiroglu, M., Charitakis, K., Hakeem, A., Toutouzas, K. P., Leesar, M. A., & Marmagkiolis, K. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26379 · Cited by 190
“Older patients with head and neck malignancies or lymphoma who are receiving supraclavicular radiation remain at significantly higher short- and long-term risk for cerebrovascular events [125,126] and thus baseline and more aggressive surveillance via carotid artery screening and subsequent treatment should be advised…”
BackgroundRecht, A., Comen, E. A., Fine, R. E., Fleming, G. F., Hardenbergh, P. H., Ho, A. Y., Hudis, C. A., Hwang, E. S., Kirshner, J. J., Morrow, M., et al. (2016) · Practical Radiation Oncology · doi:10.1016/j.prro.2016.08.009 · Cited by 185
Ischemic heart disease in women: A focus on risk factors
Mehta, P. K., Wei, J., & Wenger, N. K. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.10.005 · Cited by 185
“[68] Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al.”
BackgroundRoadmap: proton therapy physics and biology
Paganetti, H., Beltran, C., Both, S., Dong, L., Flanz, J., Furutani, K., Grassberger, C., Grosshans, D. R., Knopf, A.-C., Langendijk, J. A., et al. (2021) · Physics in Medicine & Biology · doi:10.1088/1361-6560/abcd16 · Cited by 175
Mammography screening: A major issue in medicine
Autier, P., & Boniol, M. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2017.11.002 · Cited by 177
Andreassi, M. G., Piccaluga, E., Gargani, L., Sabatino, L., Borghini, A., Faita, F., Bruno, R. M., Padovani, R., Guagliumi, G., & Picano, E. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.12.233 · Cited by 181
Pathology and biology of radiation-induced cardiac disease
Tapio, S. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw064 · Cited by 175
“The recent case–control study among women who underwent radiotherapy for breast cancer indicates that the rate of ischemic heart disease is significantly increased, even with doses <2 Gy [14].”
BackgroundIliescu, C., Grines, C. L., Herrmann, J., Yang, E. H., Cilingiroglu, M., Charitakis, K., Hakeem, A., Toutouzas, K., Leesar, M. A., & Marmagkiolis, K. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26375 · Cited by 186
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update
Park, K. U., Somerfield, M. R., Anne, N., Brackstone, M., Conlin, A. K., Couto, H. L., Dengel, L. T., Eisen, A. F., Harvey, B. E., Hawley, J. R., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-00099 · Cited by 217
Klein Hesselink, E. N., Klein Hesselink, M. S., de Bock, G. H., Gansevoort, R. T., Bakker, S. J. L., Vredeveld, E. J., van der Horst-Schrivers, A. N. A., van der Horst, I. C. C., Kamphuisen, P. W., Plukker, J. T. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1043 · Cited by 183
“In patients with breast cancer, local adverse effects of radiation on coronary arteries have been described.(28) In our study, neither A”
BackgroundJacob, S., Camilleri, J., Derreumaux, S., Walker, V., Lairez, O., Lapeyre, M., Bruguière, E., Pathak, A., Bernier, M.-O., Laurier, D., et al. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1234-z · Cited by 175
“In Darby’s study [5], estimated mean doses to the LAD and MHD were also Table 3 Association parameters between mean dose to the left ventricle and coronary arteries and the mean heart dose”
BackgroundInfluentialLong-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review
Gebauer, J., Higham, C., Langer, T., Denzer, C., & Brabant, G. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00092 · Cited by 161
Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy
Shah, C., Badiyan, S., Berry, S., Khan, A. J., Goyal, S., Schulte, K., Nanavati, A., Lynch, M., & Vicini, F. A. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.04.009 · Cited by 169
“increase in cardiac morbidity and mortality, there are significant limitations to these data [7,8].”
BackgroundUpdates in the Treatment of Breast Cancer with Radiotherapy
Castaneda, S. A., & Strasser, J. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.01.013 · Cited by 168
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity
Omland, T., Heck, S. L., & Gulati, G. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.01.101 · Cited by 200
“4% per Gray mean dose to the heart.(57) Other identified risk factors include young age, concomitant anthracycline treatment, cardiovascular risk factors, and preexisting cardiovascular disease.”
BackgroundMaraldo, M. V., Giusti, F., Vogelius, I. R., Lundemann, M., van der Kaaij, M. A. E., Ramadan, S., Meulemans, B., Henry-Amar, M., Aleman, B. M. P., Raemaekers, J., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00153-2 · Cited by 169
Stam, B., Peulen, H., Guckenberger, M., Mantel, F., Hope, A., Werner-Wasik, M., Belderbos, J., Grills, I., O'Connell, N., & Sonke, J.-J. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.04.017 · Cited by 168
Gillies, M., Richardson, D. B., Cardis, E., Daniels, R. D., O'Hagan, J. A., Haylock, R., Laurier, D., Leuraud, K., Moissonnier, M., Schubauer‐Berigan, M. K., et al. (2017) · Radiation Research · doi:10.1667/rr14608.1 · Cited by 178
“At higher, yet still moderate dose rates, studies of patients treated by radiotherapy of the left breast also demonstrate clear evidence of subsequent cardiovascular disease mortality risk several years postirradiation (8–12).”
Cardiovascular disease after cancer therapy
Aleman, B. M. P., Moser, E. C., Nuver, J., Suter, T. M., Maraldo, M. V., Specht, L., Vrieling, C., & Darby, S. C. (2014) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2014.03.002 · Cited by 168
“Effects of specific doses to the whole heart and to specific cardiac substructures have only been assessed in a few studies [13,14,23].”
BackgroundResultInfluentialSelf-citationMaleszewski, J. J., Bois, M. C., Bois, J. P., Young, P. M., Stulak, J. M., & Klarich, K. W. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.026 · Cited by 181
Major, T., Gutiérrez, C., Guix, B., van Limbergen, E., Strnad, V., & Polgár, C. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.12.006 · Cited by 163
Thoracic Radiation Normal Tissue Injury
Simone, C. B. (2017) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2017.04.009 · Cited by 158
F. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162
“itant administration of other cardiotoxic drugs and patient factors (younger age, traditional risk factors [170], history of heart disease).”
Low dose or low dose rate ionizing radiation-induced health effect in the human
Tang, F. R., & Loganovsky, K. (2018) · Journal of Environmental Radioactivity · doi:10.1016/j.jenvrad.2018.05.018 · Cited by 169
“, 2009), or in women after radiotherapy for breast cancer (Darby et al., 2013) and in the atomic bomb survivors with radiation exposure above 500mSv (Shimizu et al.”
BackgroundReview of medical radiography and tomography with proton beams
Johnson, R. P. (2017) · Reports on Progress in Physics · doi:10.1088/1361-6633/aa8b1d · Cited by 160
“For example, x-ray irradiation of breast cancers is known to increase the risk of subsequent major coronary events [7, 8], but IMPT can deliver the needed irradiation with minimal dose to the heart.”
BackgroundOsman, S. O. S., Hol, S., Poortmans, P. M., & Essers, M. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.04.004 · Cited by 159
“4% per Gy with no apparent threshold [13].”
BackgroundBreast cancer therapy-associated cardiovascular disease
Zagar, T. M., Cardinale, D. M., & Marks, L. B. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.171 · Cited by 161
Ramin, C. A., Schaeffer, M. L., Zheng, Z., Connor, A. E., Hoffman–Bolton, J., Lau, B. M., & Visvanathan, K. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa096 · Cited by 162
“late-effect up to 20 years after treatment (38).”
BackgroundRadiation-Associated Cardiac Disease
Desai, M. Y., Jellis, C. L., Kotecha, R. R., Johnston, D. R., & Griffin, B. P. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.04.028 · Cited by 155
“Although these measures will likely reduce the risk of RACD, current outcomes in RACD still remain considerably influenced by historical practices (8,9).”
BackgroundIonizing radiation-induced circulatory and metabolic diseases
Tapio, S., Little, M. P., Kaiser, J. C., Impens, N. R. E. N., Hamada, N., Georgakilas, A. G., Simar, D., & Salomaa, S. I. (2020) · Environment International · doi:10.1016/j.envint.2020.106235 · Cited by 166
“…2016; Mulrooney et al., 2009), the Netherlands HL studies (Cutter et al., 2015; van Nimwegen et al., 2017; van Nimwegen et al., 2016), the Nordic breast cancer study (Darby et al., 2013) and the US peptic ulcer study (Little et al., 2012b), and adjustment for these did not materially alter results.”
InfluentialThe Role of Optical Surface Imaging Systems in Radiation Therapy
Hoisak, J. D. P., & Pawlicki, T. A. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.02.003 · Cited by 152
“31 A focus of breast radiation treatment research has been on reducing dose to normal tissues and reduced late side effects.”
BackgroundCardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review)
Baselet, B., Rombouts, C., Benotmane, M. A., Baatout, S., & Aerts, A. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2777 · Cited by 161
“Darby et al formulated two hypotheses for biological mechanisms that lead to increased morbidity and mortality from coronary artery disease following radiation exposure (5).”
Understanding Radiation-induced Cardiovascular Damage and Strategies for Intervention
Stewart, F. A., Seemann, I., Hoving, S., & Russell, N. S. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.012 · Cited by 159
Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy
Virén, T., Heikkilä, J., Myllyoja, K., Vuolukka, K., Lahtinen, T., & Seppälä, J. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0392-x · Cited by 149
“Unfortunately, a number of patients develop radiation related complications such as breast fibrosis, changes in the breast appearance and late pulmonary and cardiovascular complications [2-4].”
BackgroundInfluentialThe Evolution of Radiation Therapy in Treating Cancer
Abshire, D., & Lang, M. K. (2018) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2018.03.006 · Cited by 149
Taylor, C., McGale, P., Brønnum, D., Correa, C. R., Cutter, D. J., Duane, F. K., Gigante, B., Jensen, M., Lorenzen, E. L., Rahimi, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6351 · Cited by 149
“Several studies have provided insight into the risk of radiationrelated heart disease after breast cancer radiotherapy by comparing the numbers of womenwith left- and right-sided breast cancer and calculating the likely difference in cardiac dose between the two groups.(7,8) Here, we extend this technique by consideri…”
BackgroundMethodInfluentialSelf-citationPrevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease
Desai, M. Y., Windecker, S., Lancellotti, P., Bax, J. J., Griffin, B. P., Cahlon, O., & Johnston, D. R. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.006 · Cited by 160
“BC (963 cases and 1,205 controls of 2,168 breast cancer survivors between 1958 and 2001) (5) Mean cardiac dose 4.”
BackgroundIschemic heart disease after breast cancer radiotherapy.
Darby, S. C., Ewertz, M., & Hall, P. (2013) · PubMed · doi:10.1056/nejmc1304601 · Cited by 47
Self-citationTrends in Radiation Therapy among Cancer Survivors in the United States, 2000–2030
Bryant, A. K., Banegas, M. P., Martínez, M. E., Mell, L. K., & Murphy, J. D. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-1023 · Cited by 149
“Breast cancer historically carried a nontrivial risk of cardiovascular mortality from radiation to the heart, but in recent years, this risk has decreased because of improved efforts to spare the heart from radiation (21, 22).”
BackgroundCommon Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis
Leiva, O., AbdelHameid, D., Connors, J. M., Cannon, C. P., & Bhatt, D. L. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.08.011 · Cited by 155
“Radiation, which is used in the treatment of various types of cancers, has been shown to increase the risk for ischemic heart disease (102-104).”
BackgroundJin, G.-H., Chen, L.-X., Deng, X.-W., Liu, X.-W., Huang, Y., & Huang, X.-B. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-89 · Cited by 146
“reported that exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease [26].”
BackgroundEffects of ionizing radiation on the heart
Boerma, M., Sridharan, V., Mao, X. W., Nelson, G. A., Cheema, A. K., Koturbash, I., Singh, S. P., Tackett, A. J., & Hauer‐Jensen, M. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.07.003 · Cited by 157
Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?
Beukema, J. C., van Luijk, P., Widder, J., Langendijk, J. A., & Muijs, C. T. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.037 · Cited by 144
“[1] reported on the relationship between radiation dose and major cardiac events among breast cancer patients and compared them with a population-based matched control group.”
BackgroundResultHAMO, C. E., Bloom, M. W., Cardinale, D. M., Ky, B., Nohria, A., Baer, L. N., Skopicki, H. A., Lenihan, D. J., Gheorghiade, M., Lyon, A. R., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002843 · Cited by 162
Skyttä, T., TUOHINEN, S. S., Boman, E. L., Virtanen, V., Raatikainen, P. M. J., & Kellokumpu‐Lehtinen, P. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0436-2 · Cited by 141
“9 Gy (retrospective analysis) [4] to 9 Gy (prospective analysis) [5].”
BackgroundInfluentialESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy
Aznar, M. C., Carrasco, P., Corradini, S., Mast, M. E., McNair, H. A., Meattini, I., Persson, G. F., & van Haaren, P. M. A. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.109734 · Cited by 139
Strnad, V., Hannoun‐Lévi, J., Guinot, J. L., Lössl, K., Kauer-Dorner, D., Resch, A., Kovács, G., Major, T., & Limbergen, E. V. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.06.010 · Cited by 138
The Cancer Patient and Cardiology
Zamorano, J. L., Gottfridsson, C., Asteggiano, R., Atar, D., Badimón, L., Bax, J. J., Cardinale, D. M., Cardone, A., Feijen, E. A. M., Ferdinandy, P., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1985 · Cited by 143
Grantzau, T. L., & Overgaard, J. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.08.017 · Cited by 136
Mast, M. E., van Kempen-Harteveld, L., Heijenbrok, M. W., Kalidien, Y., Rozema, H., Jansen, W., Petoukhova, A., & Struikmans, H. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.07.017 · Cited by 144
Wu, P.-H., Onodera, Y., Ichikawa, Y., Rankin, E., Giaccia, A., Watanabe, Y., Qian, W., Hashimoto, T., Shirato, H., & Nam, J.-M. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s137833 · Cited by 132
“14,15 Although lower doses are utilized for clinical treatment, 19.3% of breast cancer patients develop invasive recurrent disease following radiotherapy.”
BackgroundInfluentialSmyth, L. M. L., Knight, K. A., Aarons, Y., & Wasiak, J. (2015) · Journal of Medical Radiation Sciences · doi:10.1002/jmrs.89 · Cited by 145
“estimate that a 1 Gy increase in mean heart dose equates to a 4% increase in the risk of late heart disease and Darby et al.(7) estimate that a 1 Gy increase in mean heart dose equates to a 7.”
BackgroundInfluentialNew challenges in high-energy particle radiobiology
Durante, M. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130626 · Cited by 123
“A clear correlation between radiation dose to the heart in breast cancer patients and late ischaemic heart diseases has been recently shown in a cohort of Swedish and Danish females treated by radiotherapy for breast cancer.(137) A-bomb survivors’ data also support these results.”
ResultLong-term spaceflight and the cardiovascular system
Vernice, N. A., Meydan, C., Afshinnekoo, E., & Mason, C. E. (2020) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaa022 · Cited by 136
Radiation-Induced Vascular Disease—A State-of-the-Art Review
Yang, E. H., Marmagkiolis, K., Balanescu, D. V., Hakeem, A., Donisan, T., Finch, W., Virmani, R., Herrman, J., Çilingiroğlu, M., Grines, C. L., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.652761 · Cited by 130
“In the largest study to date, 2168 breast cancer survivors undergoing radiation therapy were studied in Denmark (64).”
BackgroundRadiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
Jacobse, J. N., Duane, F. K., Boekel, N. B., Schaapveld, M., Hauptmann, M., Hooning, M. J., Seynaeve, C., Baaijens, M. H. A., Gietema, J. A., Darby, S. C., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.10.025 · Cited by 129
“Conclusions: MI rate after radiation for BC increases linearly with MWHD. Reductions in MWHD are expected to contribute to better cardiovascular health of BC survivors.”
BackgroundResultInfluentialSelf-citationCardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors
Boekel, N. B., Schaapveld, M., Gietema, J. A., Russell, N. S., Poortmans, P. M., Theuws, J. C. M., Schinagl, D. A. X., Rietveld, D. H. F., Versteegh, M. I. M., Visser, O. J., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.040 · Cited by 134
Wang, K., Pearlstein, K. A., Patchett, N. D., Deal, A. M., Mavroidis, P., Jensen, B. C., Lipner, M. B., Zagar, T. M., Wang, Y., Lee, C. B., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.10.001 · Cited by 128
Dabaja, B. S., Hoppe, B. S., Plastaras, J. P., Newhauser, W. D., ROSOLOVÁ, K., Flampouri, S., Mohan, R., Mikhaeel, N. G., Kirova, Y., Specht, L., et al. (2018) · Blood · doi:10.1182/blood-2018-03-837633 · Cited by 128
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America
Bloom, M. W., Vo, J. B., Rodgers, J. E., FERRARI, A. M., Nohria, A., Deswal, A. M., Cheng, R. K.-H., Kittleson, M. M., Upshaw, J. N., Palaskas, N. L., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.08.045 · Cited by 140
Novel concepts in radiation-induced cardiovascular disease
Cuomo, J. R., Sharma, G. K., Conger, P. D., & Weintraub, N. L. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i9.504 · Cited by 133
Albano, D., Benenati, M., Bruno, A., Bruno, F., Calandri, M., Caruso, D., Cozzi, D., Robertis, R. D., Gentili, F., Grazzini, I., et al. (2021) · Insights into Imaging · doi:10.1186/s13244-021-01017-2 · Cited by 128
“[38] reported a close association between the mean heart dose and cardiac events with a significant increase of 7.”
BackgroundRelationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ
Zee, K. J. V., Subhedar, P. D., Olcese, C., Patil, S. N., & Morrow, M. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001454 · Cited by 126
Hahn, E., Jiang, H., Ng, A., Bashir, S., Ahmed, S. T., Tsang, R. W. C., Sun, A. Y., Gospodarowicz, M. K., & Hodgson, D. C. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.03.026 · Cited by 126
Henson, K. E., Reulen, R. C., Winter, D. L., Bright, C. J., Fidler-Benaoudia, M. M., Frobisher, C., Guha, J., Wong, K. F., Kelly, J. S., Edgar, A. B., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022514 · Cited by 127
Self-citationGold Nanorod-Assisted Photothermal Therapy and Improvement Strategies
Taylor, M. L., Wilson, R., Amrhein, K., & Huang, X. (2022) · Bioengineering · doi:10.3390/bioengineering9050200 · Cited by 128
“On the other hand, surgery, which is often used as a frontline defense for removing primary tumors, is invasive and can increase the risk of developing secondary cancers [7], while radiotherapy and immunotherapy can negatively impact the immune system [8,9].”
BackgroundRadiation and circulatory disease
Little, M. P. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.07.008 · Cited by 119
“[17] The Nordic case-control study of Darby et al [46] assessed IHD incidence in a group of women treated for breast cancer.”
BackgroundResultInfluentialBreast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO), Duma, M. N., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Harms, W., Hehr, T., et al. (2019) · Strahlentherapie und Onkologie · doi:10.1007/s00066-019-01495-w · Cited by 124
Mutter, R. W., Choi, J. I., Jimenez, R., Kirova, Y., Fagundes, M., Haffty, B. G., Amos, R. A., Bradley, J. A., Chen, P. Y., Ding, X., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.05.110 · Cited by 132
Cardiac Diseases Following Childhood Cancer Treatment
Haddy, N., Diallo, S., El‐Fayech, C., Schwartz, B., Pein, F. J. L., Hawkins, M., Veres, C., Oberlin, O., Guibout, C., Pacquement, H., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016686 · Cited by 122
Schönecker, S., Walter, F., Freislederer, P., Marisch, C., Scheithauer, H., Harbeck, N., Corradini, S., & Belka, C. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0716-5 · Cited by 122
“Using these risk models [29], the rate of major coronary events could theoretically be decreased by roughly 10 % through the use of DIBH.”
BackgroundMethodInfluentialA Systematic Review of Heart Dose in Breast Radiotherapy
Drost, L., Yee, C., Lam, H., Zhang, L., Wronski, M., McCann, C., Lee, J., Vesprini, D., Leung, E., & Chow, E. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.05.010 · Cited by 125
Wennstig, A.-K., Garmo, H., Isacsson, U., Gagliardi, G., Rintelä, N., Lagerqvist, B., Holmberg, L., BLOMQVIST, C. P., Sund, M., & Nilsson, G. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1242-z · Cited by 121
Self-citationACE inhibition attenuates radiation-induced cardiopulmonary damage
van der Veen, S. J., Ghobadi, G., de Boer, R. A., Faber, H., Cannon, M. V., Nagle, P. W., Brandenburg, S., Langendijk, J. A., van Luijk, P., & Coppes, R. P. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.017 · Cited by 121
“4% with each gray of radiation to the heart [3], and patients treated for thoracic cancers still receive relevant doses to the heart, it is therefore of great clinical importance to find strategies to reduce this toxicity.”
BackgroundNCCN Guidelines Insights: Survivorship, Version 2.2020
Denlinger, C. S., Sanft, T. B., Moslehi, J. J., Overholser, L., Armenian, S. H., Baker, K. S., Broderick, G. A., Demark‐Wahnefried, W., Friedman, D. L., Goldman, M. E., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0037 · Cited by 124
Breast cancer survival among young women: a review of the role of modifiable lifestyle factors
Brenner, D. R., Brockton, N. T., Kotsopoulos, J., Cotterchio, M., Boucher, B. A., Courneya, K. S., Knight, J. A., Olivotto, I. A., Quan, M. L., & Friedenreich, C. M. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0726-5 · Cited by 140
Cardiotoxicity and Oncological Treatments
Schlitt, A., Jordan, K., Vordermark, D., Schwamborn, J., Langer, T., & Thomssen, C. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0161 · Cited by 134
Délinéation des organes à risque et contraintes dosimétriques
Noël, G., Antoni, D., Barillot, I., & Chauvet, B. (2016) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2016.07.032 · Cited by 123
Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed
Vijayvergia, N., & Denlinger, C. S. (2015) · Journal of Personalized Medicine · doi:10.3390/jpm5030243 · Cited by 128
“Mediastinal radiotherapy and systemic chemotherapy can also induce late cardiovascular adverse effects like myocardial infarction and cardiac insufficiency [11,12].”
BackgroundPostoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer
Speers, C. W., & Pierce, L. J. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5805 · Cited by 117
Recht, A., Comen, E. A., Fine, R. E., Fleming, G. F., Hardenbergh, P. H., Ho, A. Y., Hudis, C. A., Hwang, E. S., Kirshner, J. J., Morrow, M., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5558-8 · Cited by 117
Chow, E. J., Baker, K. S., Lee, S. J., Flowers, M. E. D., Cushing-Haugen, K. L., Inamoto, Y., Khera, N., Leisenring, W. M., Syrjala, K. L., & Martin, P. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.6582 · Cited by 115
“HCT survivors with conventional cardiovascular risk factors such as obesity, hypertension, dyslipidemia, and diabetes seem to have a substantially greater risk of more serious cardiovascular disease, even after accounting for cardiotoxic cancer treatments, similar to findings from general cancer survivors.(18,19) The…”
ResultDosimetry of ionising radiation in modern radiation oncology
Kron, T., Lehmann, J., & Greer, P. B. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/14/r167 · Cited by 116
Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage
Choi, K. J., Nam, J.-K., Kim, J.-H., Choi, S., & Lee, Y. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0439-4 · Cited by 120
Lorenzen, E. L., Taylor, C., Maraldo, M. V., Nielsen, M. H., Offersen, B. V., Andersen, M. R., ODwyer, D. B., Larsen, L., Duxbury, S., Jhitta, B., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.025 · Cited by 120
Self-citationA review of non-cancer effects, especially circulatory and ocular diseases
Little, M. P. (2013) · Radiation and Environmental Biophysics · doi:10.1007/s00411-013-0484-7 · Cited by 112
Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer
Boero, I. J., Paravati, A. J., Triplett, D. P., Hwang, L., Matsuno, R. K., Gillespie, E. F., Yashar, C. M., Moiseenko, V., Einck, J. P., Mell, L. K., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.12.018 · Cited by 118
“Given that previous research has shown an association between ischemic heart disease and breast radiation (4, 10, 12, 17, 18), we focused on studying cardiac ischemia and its sequelae.”
BackgroundResultRadiation-Induced Cardiovascular Disease: A Clinical Perspective
Yusuf, S. W., Venkatesulu, B. P., Mahadevan, L. S. K., & Krishnan, S. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00066 · Cited by 115
“Prog Cardiovasc Dis (1991) 33(5):299–311.”
BackgroundInfluentialSwanner, J. L., Fahrenholtz, C. D., Tenvooren, I., Bernish, B. W., Sears, J. J., Hooker, A., Furdui, C. M., Alli, E., Li, W., Donati, G. L., et al. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00021 · Cited by 117
Radiation-Induced Cardiovascular Disease
Raghunathan, D., Khilji, M. I., Hassan, S. A., & Yusuf, S. W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0658-x · Cited by 113
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.